Delve into the hidden innovation system of drug repurposing. When patents expire and commercial value fades, a new wave of ...

June 2026 saw drug development in oncology and neurology continue and biotech deals over small molecules and RNA therapies ...

Parabilis Medicines, NewLimit, Enliven Therapeutics, and Kardigan bagged the biggest biotech funding rounds overall in June 2026.

Novartis’ current strategy can be traced back to October 2023, when the Swiss pharma completed the spin-off of Sandoz, its generics and biosimilars business. The company described the move as the ...

Long renowned for its rich history, striking architecture, and thriving technology sector, Prague – and Czechia as a whole – is increasingly gaining recognition for something else: a fast-growing life ...

Despite decades of progress in oncology, the majority of cancer drugs that enter clinical trials never reach the market and the patients who need them most. Late-stage failure remains one of the most ...

What readers will learn: Reduce manual effort through one automated, closed T cell manufacturing workflow, transferred across multiple sites with reproducible outcomes. Strengthen QC readiness through ...